CTI BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Aug '25 Aug 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	49,985	-	-	-
Enterprise Value	60,605	-	-	-
Debt / Equity Ratio	3.88	8.12	-15.16	-
Debt / EBITDA Ratio	6.06	6.94	13.67	-
Asset Turnover	-	0.17	-	-
Quick Ratio	0.33	0.36	0.40	-
Current Ratio	0.44	0.39	0.50	-
Return on Equity (ROE)	-	-146.77%	-	-
Return on Assets (ROA)	-	1.78%	-	-
Return on Capital (ROIC)	-	2.94%	-	-
Return on Capital Employed (ROCE)	1.90%	2.50%	-	-
Buyback Yield / Dilution	-25.64%	-13.37%	-6.38%	-

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q